Trial Profile
Randomized Phase II Trial: Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Tretinoin (Primary) ; Cisplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Pharmacogenomic; Therapeutic Use
- 22 Jan 2010 New trial record